Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Study of Safety and Preliminary Efficacy for LDK378 in Japanese Patients With Genetic Alterations in Anaplastic Lymphoma Kinase (ALK)
- Status
- COMPLETED
- Phase
- PHASE1
Phase Ib of Abiraterone Acetate Plus BEZ235 or BKM120 in Castration-resistant Prostate Cancer (CRPC) Patients
- Status
- COMPLETED
- Phase
- PHASE1
MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone
- Status
- TERMINATED
- Phase
- PHASE3
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
- Status
- TERMINATED
- Phase
- PHASE3
Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
- Status
- TERMINATED
- Phase
- PHASE2
4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).
- Status
- TERMINATED
- Phase
- PHASE2
Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis.
- Status
- COMPLETED
- Phase
- PHASE4
A Study of LCZ696 in Subjects With Mild and Moderate Hepatic Impairment Compared With Normal Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE2
ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon
- Status
- WITHDRAWN
- Phase
- PHASE4
Efficacy, Safety and Pharmacokinetics of Artemether-lumefantrine Dispersible Tablet in the Treatment of Malaria in Infants < 5 kg
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention
- Status
- WITHDRAWN
- Phase
- PHASE2